When these circumstances are considered together with the assumption that ZNF518B is involved in EMT, which, in turn, has been associated to modifications in the histone epigenetic marks22, the ZNF518B gene might be added to the list of epigenetic targets for cancer therapy. Here, ZNF518B is linked to cancer.